HB 575-FN (2023): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“HB 575-FN (2023): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.” Granite Record, https://graniterecord.org/bill/2023/hb575. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). HB 575-FN (2023): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2023/hb575
Chicago
Granite Record. “HB 575-FN (2023): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2023/hb575.
BibTeX
@misc{bill-2023-hb575, title = {HB 575-FN (2023): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2023/hb575}, note = {Accessed 24 Oct. 2026} }

HB 575-FN (2023)

relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.

  • Status: Killed
  • Term: 2023-2024
  • House committee: Health, Human Services and Elderly Affairs
  • Subject: Public and Mental Health

The Story

It was introduced on January 5, 2023 and referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on February 16, 2023. The committee met in executive session on March 8, 2023 to vote on its recommendation. The majority recommended that the House kill it, and the minority recommended that the House pass it, by a vote of 11–9. The report was placed on the regular calendar. On March 23, 2023 the House voted to kill it on a roll call 192–186. On March 23, 2023 the House failed “Reconsider HB575” on a division vote 185–194, on a motion by Rep. Adjutant.

Sponsors

Hearings and Sessions

  • February 16, 2023, 10:30 AM: public hearing, House Health, Human Services and Elderly Affairs, LOB 201-203
  • March 8, 2023, 11:00 AM: executive session, House Health, Human Services and Elderly Affairs, LOB 201-203

Votes

  • March 23, 2023, House: Inexpedient to Legislate — yeas 192, nays 186, passed
  • March 23, 2023, House: Reconsider HB575 — yeas 185, nays 194, failed

The Docket

  • January 5, 2023: Introduced (in recess of) 01/05/2023 and referred to Health, Human Services and Elderly Affairs
  • February 16, 2023: Public Hearing: 02/16/2023 10:30 am LOB 201-203
  • March 8, 2023: Executive Session: 03/08/2023 11:00 am LOB 201-203
  • March 13, 2023: Majority Committee Report: Inexpedient to Legislate HB575-FN 03/13/2023 (Vote 11-9; RC)
  • March 15, 2023: Minority Committee Report: Ought to Pass
  • March 23, 2023: Inexpedient to Legislate: MA RC 192-186 03/23/2023
  • March 23, 2023: Reconsider HB575 (Rep. Adjutant): MF DV 185-194 03/23/2023

Laws It Would Change

Related Bills

  • SB 319-FN (2024): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.

From the General Court